<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02308059</url>
  </required_header>
  <id_info>
    <org_study_id>TF2012BAP13</org_study_id>
    <nct_id>NCT02308059</nct_id>
  </id_info>
  <brief_title>Ultrasonographic Evaluation of Diabetic Neuropathy</brief_title>
  <official_title>Diabetic Peripheral Neuropathy: Correlation Between Ultrasound Findings and Clinical Features</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cukurova University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cukurova University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The current study aimed to evaluate the cross-sectional area (CSA) of peripheral nerves in
      people with diabetic peripheral neuropathy using ultrasonography and correlate the CSA with
      clinical and demographic data.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with diabetic peripheral neuropathy (n=53) and a matched healthy control group
      (n=53) underwent blinded ultrasonography imaging of the sciatic, tibial and median nerves.
      Matching was performed according to patient body mass index (BMI), sex and age. CSAs of the
      nerves were recorded, and the associations between pain intensity (measured with a visual
      analog scale [VAS]), the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain
      scale, diabetes mellitus duration, BMI, HbA1c and blood glucose levels were evaluated.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Pain scores on the visual analog scale</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neuropathic pain scores on the Leeds Assessment of Neuropathic Symptoms and Signs pain scale</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">106</enrollment>
  <condition>Diabetic Peripheral Neuropathy</condition>
  <arm_group>
    <arm_group_label>Patients with diabetes mellitus</arm_group_label>
    <description>Group I; the patients with diabetes mellitus who had peripheral neuropathy as diagnosed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Group II; healthy volunteers</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ultrasonographic evaluation of nerves in diabetic patients</intervention_name>
    <description>Ultrasonographic evaluation of peripheral nerves in patients with diabetes mellitus which have peripheral neuropathy</description>
    <arm_group_label>Patients with diabetes mellitus</arm_group_label>
    <other_name>ultasonographic evaluation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ultrasonographic evaluation of nerves of healthy volunteers</intervention_name>
    <description>evaluation of peripheral nerves and correlated with group I</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Outpatients in a University Hospital
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  type 2 diabetes mellitus

          -  Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) scores ≥ 12

          -  probable diabetic peripheral neuropathy according to the diabetic peripheral
             neuropathy criteria.

        Exclusion Criteria

          -  type 1 diabetes mellitus

          -  hypothyroidism

          -  LANSS pain scale scores &lt; 12

          -  body mass index (BMI) &gt; 35

          -  current pregnancy

          -  histories of hereditary neuropathy, inflammatory neuropathy, nerve trauma, or other
             known causes of polyneuropathy; and the use of anti-neuropathic drugs.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bayram Kelle</last_name>
    <role>Principal Investigator</role>
    <affiliation>Çukurova University, Faculty of Medicine</affiliation>
  </overall_official>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 1, 2014</study_first_submitted>
  <study_first_submitted_qc>December 2, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2014</study_first_posted>
  <last_update_submitted>December 2, 2014</last_update_submitted>
  <last_update_submitted_qc>December 2, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 4, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cukurova University</investigator_affiliation>
    <investigator_full_name>Bayram Kelle</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Nervous System Diseases</mesh_term>
    <mesh_term>Diabetic Neuropathies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

